News

AKF announces sponsorship from Novartis Pharmaceuticals Corporation for education and awareness campaigns for two rare kidney diseases: complement 3 glomerulopa...

As a part of its Unknown Causes of Kidney Disease (UCKD) Project, AKF surveyed health care providers to understand opportunities and barriers in diagnosing chro...

AKF is pleased to announce that Vertex Pharmaceuticals Inc. is providing support for its education and awareness campaign about the apolipoprotein L1 (APOL1) ge...

Researchers from Stanford University School of Medicine, Brigham and Women's Hospital and Massachusetts General Hospital will study health disparities, ren...

Digital and print resources focus on rare disease that causes kidney dysfunction in infants and children